Clinical Trial Update: Effects and Plasma Concentration of Ticagrelor, After Crushed and Non-crushed Intake, After Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects and plasma concentration of ticagrelor when crushed vs non-crushed in Acute Coronary Syndrome patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED